You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Johnson and Johnson
Colorcon
Medtronic
McKinsey

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Drug Price Trends for FENOFIBRATE


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for FENOFIBRATE

Average Pharmacy Cost for FENOFIBRATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FENOFIBRATE 200 MG CAPSULE 69097-0896-07 0.69360 EACH 2020-02-19
FENOFIBRATE 134 MG CAPSULE 69097-0895-07 0.36046 EACH 2020-02-19
FENOFIBRATE 67 MG CAPSULE 69097-0894-07 0.33177 EACH 2020-02-19
FENOFIBRATE 48 MG TABLET 69097-0459-05 0.18847 EACH 2020-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for FENOFIBRATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FENOFIBRATE 145MG TAB Perrigo Sourcing Solutions, Inc. 45802-0132-75 90 11.06 0.12289 EACH 2018-10-01 - 2023-09-30 FSS
FENOFIBRATE 48MG TAB Perrigo Sourcing Solutions, Inc. 45802-0315-75 90 7.09 0.07878 EACH 2018-10-01 - 2023-09-30 FSS
FENOFIBRATE 48MG TAB Perrigo Sourcing Solutions, Inc. 45802-0315-75 90 6.06 0.06733 EACH 2019-01-10 - 2023-09-30 FSS
TRICOR TABLETS 145MG Abbvie US LLC 00074-3189-90 90 90.72 1.00800 EACH 2018-09-01 - 2023-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Merck
McKinsey
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.